(Q71101177)

English

Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine

scientific article published on 01 April 1996

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

title

Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine (English)

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

E Delgrange

1

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

D Maiter

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

J Donckier

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

publication date

1 April 1996

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

published in

European Journal of Endocrinology

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

volume

134

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

issue

4

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

page(s)

454-456

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

retrieved

16 October 2019

Identifiers

DOI

10.1530/EJE.0.1340454

1 reference

stated in

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

16 October 2019

1 reference

Europe PubMed Central

PubMed ID

8640297

reference URL

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8640297%20AND%20SRC:MED&resulttype=core&format=json

(Q71101177)

Effects of the dopamine agonist cabergoline in patients with prolactinoma intolerant or resistant to bromocriptine

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)